Use of In silico Approaches for Next Generation Sequencing Bioinformatic Pipeline Validation

Publication Date: October 12, 2022
Last Updated: October 24, 2022

General Recommendations

The laboratory may use in silico data files to supplement NGS analytical validation, particularly to assess analytical sensitivity or false-negative rates for specific variants; however, in silico data files cannot supplant the use of physical samples (eg, patient samples).
6731

Overview

Title

Use of In silico Approaches for Next Generation Sequencing Bioinformatic Pipeline Validation

Authoring Organization

Association for Molecular Pathology